This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Gilead Sciences, Inc.. Active years: 2017-2018.
Company Filing History:
Years Active: 2017-2018
Title: The Innovative Contributions of Dustin Bringley
Introduction
Dustin Bringley is a notable inventor based in San Carlos, CA. He has made significant contributions to the field of antiviral compounds, particularly in the development of crystalline forms of these compounds. With a total of 2 patents to his name, Bringley continues to push the boundaries of pharmaceutical innovation.
Latest Patents
Bringley's latest patents focus on crystalline forms of an antiviral compound. These include the anti-HCV compound (1aR,5S,8S,9S,10R,22aR)-5-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}cyclopropyl]-9-ethyl-18,18-difluoro-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxamide (Compound I). These crystalline forms have been prepared and characterized in the solid state, and the patents also provide processes of manufacture and methods of using these crystalline forms.
Career Highlights
Dustin Bringley is currently employed at Gilead Sciences, Inc., where he applies his expertise in antiviral research. His work has been instrumental in advancing the understanding and application of antiviral compounds in the pharmaceutical industry.
Collaborations
Bringley has collaborated with notable colleagues such as Peter C Fung and Katie Ann Keaton. These collaborations have further enhanced the innovative work being done in the field of antiviral research.
Conclusion
Dustin Bringley is a prominent inventor whose work in antiviral compounds has made a significant impact in the pharmaceutical industry. His contributions continue to pave the way for future innovations in this critical area of research.